DHG Pharmaceutical JSC (HOSE:DHG)

Market Cap	12.77T
Revenue (ttm)	4.82T
Net Income (ttm)	796.24B
Shares Out	130.75M
EPS (ttm)	6,089.52
PE Ratio	16.04
Forward PE	14.70
Dividend	10,000.00 (10.24%)
Ex-Dividend Date	May 23, 2025

Volume	26,471
Average Volume	41,315
Open	98,600
Previous Close	97,700
Day's Range	97,300 - 98,700
52-Week Range	87,000 - 125,900
Beta	0.38
RSI	43.39
Earnings Date	Jul 18, 2025

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures and trades in dietary supplements and pharmaceuticals cosmetics. The company exports its products to approximately 20 countries. The company was founded...

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 2,806
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DHG

Financial Performance

In 2024, DHG Pharmaceutical JSC's revenue was 4.88 trillion, a decrease of -2.60% compared to the previous year's 5.02 trillion. Earnings were 753.55 billion, a decrease of -25.91%.